Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-22-041730

Chief Operating Officer sold 3,125 shares at an average $10.22 ($31,943)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ADAMS R MARK Chief Operating Officer 2022-07-07 Sale −825 $9.53 $7,862 122,068 D
ADAMS R MARK Chief Operating Officer 2022-07-08 Sale −2,300 $10.47 $24,081 119,768 D
Open-market sales · 3,125 sh · avg $10.22 · $31,943
Loading xslF345X03/doc4.xml…